
TL;DR
The FDA has authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System, the first wearable device to monitor both ketone and glucose levels continuously. This breakthrough allows for real-time tracking, potentially preventing life-threatening diabetic ketoacidosis in patients with diabetes.
✦ Why It Matters
Consider integrating the Libre Duo into diabetes management plans to enhance patient safety.
Key Takeaways
How It Works
The Libre Duo continuously measures glucose and ketone levels in interstitial fluid beneath the skin, providing updates every minute. This data is transmitted wirelessly to a smartphone app, where users can view their current levels and trends, enabling proactive management of their condition.
Related